Priority Date: 31.01.12 (IN 2012DEL262)

SUBSTITUTED 4,5-DIHYDRO-2H-BENZO[E]INDAZOLE-9-CARBOXYLATES FOR THE TREATMENT OF DIABETES AND RELATED DISORDERS

  • Application ID: EP13708242
  • Status: PATENT GRANTED

Applicant

Attorneys

operating since 1897
1142.11
Headquarter in Malmö and 14 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing
operating since 1897
1142.11
Headquarter in Malmö and 14 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY) is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 189 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 31.01.2012 - Priority Date (IN 2012DEL262)
  • 08.08.2013 - Publication A1 (WO2013114403)
  • 10.12.2014 - Publication A1 (EP2809654)
  • 12.04.2017 - Publication B1 (EP2809654)